Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
6 trials
Recent
Start date
Enrollment
Phase 3
×
Has announcements
×
Carcinoma
×
Clear all
Filters
3
NCT03703297
2025-11-21
ADRIATIC
AstraZeneca
Phase 3
Active not recruiting
730 enrolled
19 charts
1 FDA
NCT04035486
2025-10-10
FLAURA2
AstraZeneca
Phase 3
Active not recruiting
587 enrolled
44 charts
1 FDA
NCT03800134
2025-06-11
AEGEAN
AstraZeneca
Phase 3
Active not recruiting
825 enrolled
1 FDA
NCT02737501
2021-08-20
ALTA-1L
Takeda
Phase 3
Completed
275 enrolled
23 charts
2 FDA
NCT02367781
2021-08-09
IMpower130
Hoffmann-La Roche
Phase 3
Completed
723 enrolled
28 charts
1 FDA
NCT02793128
2020-12-22
Olympus
UroGen Pharma Ltd.
Phase 3
Completed
71 enrolled
16 charts
2 FDA